Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Rose DiMartinoDirector | abrdn Healthcare InvestorsHQH | Open-market buy | 24/07/16 | 24/07/18 | 1,000 sh | $18.88 | $18,880 | No record |
Kathleen GoetzDirector | abrdn Healthcare InvestorsHQH | Open-market buy | 24/04/09 | 24/04/12 | 525 sh | $16.42 | $8,620.5 | +94.7% |
Alan R. GoodsonVice President | abrdn Healthcare InvestorsHQH | Open-market buy | 23/12/21 | 24/01/09 | 170 sh | $16.13 | $2,742.1 | No record |
Todd ReitDirector | abrdn Healthcare InvestorsHQH | Open-market buy | 24/01/02 | 24/01/04 | 1,000 sh | $16.93 | $16,930 | No record |
Bill MaherDirector | abrdn Healthcare InvestorsHQH | Open-market buy | 23/12/28 | 24/01/02 | 1,000 sh | $16.58 | $16,580 | No record |
Daniel R. OmsteadPresident | abrdn Healthcare InvestorsHQH | Open-market buy | 23/09/25 | 23/09/25 | 9,500 sh | $15.63 | $148,485 | +5.6% |
Daniel R. OmsteadPresident | abrdn Healthcare InvestorsHQH | Open-market buy | 23/09/20 | 23/09/20 | 9,500 sh | $15.88 | $150,860 | +6.0% |